Skip to Main Content

Rise and shine, everyone, another busy day is on the way. The holiday season may be fast approaching but there is still work to be done. After all, the world continues to spin no matter how hard we try to slow it down. So please join us as we reach for another cup of stimulation — or grab a bottle of water, if you prefer — and get ready to embrace the familiar rituals. Meanwhile, here are a few items of interest to help you along. Have a wonderful day and, of course, do stay in touch.

Novartis (NVS) aims to give away 100 doses of its $2.1 million-per-patient Zolgensma for spinal muscular atrophy in 2020 in a program one patient group worried is a “health lottery” that could neglect some babies, Reuters says. The program would apply to countries where the medicine is not yet approved for the rare genetic disorder that affects only about 1 in 10,000 live births. But regulatory decisions in Europe and Japan have been delayed until 2020, curbing access that Novartis hopes to partially address where giveaways are allowed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!